Market Cap | 15.28M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -57.29M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -2.00% |
Sales | 9.22M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -30.00% |
Dividend | N/A | Price/Book | 0.11 | EPS next 5Y | - | 52W High Chg | -79.00% |
Recommedations | 2.50 | Quick Ratio | 11.74 | Shares Outstanding | 9.24M | 52W Low Chg | 24.00% |
Insider Own | 67.22% | ROA | -4.47% | Shares Float | 3.03M | Beta | 1.27 |
Inst Own | 2.50% | ROE | -52.16% | Shares Shorted/Prior | 4.25K/11.07K | Price | 1.66 |
Gross Margin | 17.18% | Profit Margin | - | Avg. Volume | 46,296 | Target Price | 2.02 |
Oper. Margin | -221.91% | Earnings Date | - | Volume | 26,872 | Change | -2.07% |
Alset Inc. engages in the real estate development, financial services, digital transformation technologies, biohealth activities, and consumer products businesses in the United States, Singapore, Hong Kong, Australia, and South Korea. It operates through four segments: Real Estate, Digital Transformation Technology, Biohealth, and Other Business Activities segments. The Real Estate segment develops property projects and participates in third-party property development projects; and owns, operates, and manages real estate development projects with a focus on land subdivision developments and house rental projects. Its Digital Transformation Technology segment provides support, implementation, and development services with various technologies, including blockchain, e-commerce, social media, and artificial intelligent customer service application and metaverse services. Its technology platform focuses on business-to-business solutions, such as communications and workflow through instant messaging systems, social media, e-commerce and payment systems, direct marketing platforms, e-real estate, brand protection, and counterfeit and fraud detection; and mobile application product development and other businesses, including information technology services to end-users, service providers, and other commercial users through multiple platforms. The Biohealth segment engages in developing, researching, testing, manufacturing, licensing, and distributing biohealth products and services. Its Other Business Activities segment offers corporate strategy and business development, asset management, corporate restructuring, and leveraged buy-out expertise services. It operates cafes in Singapore and South Korea. The company was formerly known as Alset EHome International Inc. and changed its name to Alset Inc. in October 2022. The company was incorporated in 2018 and is headquartered in Bethesda, Maryland.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Chan Heng Fai Ambrose | Chief Executive Offi.. Chief Executive Officer | Jun 28 | Buy | 1.69 | 20,000 | 33,800 | 4,623,818 | 06/30/23 |
Chan Heng Fai Ambrose | Chief Executive Offi.. Chief Executive Officer | May 30 | Buy | 1.8 | 200,000 | 360,000 | 4,603,818 | 06/01/23 |
Chan Heng Fai Ambrose | Chief Executive Offi.. Chief Executive Officer | Dec 20 | Buy | 0.19 | 922,384 | 175,253 | 77,078,375 | 12/22/22 |
Chan Heng Fai Ambrose | Chief Executive Offi.. Chief Executive Officer | Nov 30 | Buy | 0.236 | 500,000 | 118,000 | 76,071,355 | 12/02/22 |
Chan Heng Fai Ambrose | Chief Executive Offi.. Chief Executive Officer | Nov 23 | Buy | 0.22 | 544,325 | 119,752 | 75,571,355 | 11/28/22 |
Chan Heng Fai Ambrose | Chief Executive Offi.. Chief Executive Officer | Nov 17 | Buy | 0.17 | 342,759 | 58,269 | 74,427,030 | 11/21/22 |
Chan Heng Fai Ambrose | Chief Executive Offi.. Chief Executive Officer | Sep 30 | Buy | .2507 | 1,000,000 | 250,700 | 73,685,923 | 10/03/22 |
Chan Heng Fai Ambrose | Chief Executive Offi.. Chief Executive Officer | Apr 08 | Buy | .8263 | 135,000 | 111,550 | 37,366,633 | 04/11/22 |
Chan Heng Fai Ambrose | Chief Executive Offi.. Chief Executive Officer | Apr 07 | Buy | 0.71 | 4,377,792 | 3,108,232 | 37,231,633 | 04/08/22 |